VR Logo

Catalyst Biosciences Inc. (CBIO) download report


Healthcare | Biotechnology & Pharma Research

Catalyst Biosciences Inc. (CBIO) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation.

IPO Date: 12-Apr-2006

Pres, CEO & Director: Dr. Nassim Usman Ph.D.

Sr. VP of Fin., Interim Chief Financial & Principal Accounting Officer: Ms. Seline E. Miller CPA

Listing: NASDAQ: CBIO

Country: United States

Headquarters: South San Francisco, CA

Website: https://www.catalystbiosciences.com

Key Facts

Market cap: $47.53 Mln

Revenue (TTM): $6.67 Mln

Earnings (TTM): $-80.03 Mln

Cash: $34.82 Mln

Total Debt: $1.91 Mln

Insider's Holding: 17.13%

Liquidity: Low

52 Week range: $0.35 - 5.20

Shares outstanding: 31,477,100

10 Years Aggregate:

  • CFO: $-407.83 Mln
  • EBITDA: $-365.16 Mln
  • Net Profit: $-369.00 Mln

Stock Performance

Time Period Catalyst Biosciences (CBIO) S&P BSE Sensex S&P Small-Cap 600
YTD65.93-9.49-17.79
1 month18.90-2.87-2.72
3 months122.06-8.59-12.17
1 Year-64.300.81-15.82
3 Years-40.9110.397.14
5 Years-19.7311.116.20
10 Years-41.6212.0010.33
As on 24-Jun-2022
Year Catalyst Biosciences (CBIO) S&P Small-Cap 600 S&P BSE Sensex
2021-85.5825.2721.99
2020-7.349.5715.75
2019-13.6920.8614.38
2018-41.98-9.705.87
201739.8811.7327.91
2016-79.2324.741.95
2015-77.10-3.36-5.03